4 ms·
The fact they can trigger antibodies on a stable portion of the virus is impressive. Near the end, it sounds like a multi pronged approach is needed to deal wit
by BikiniPrince 2y ago
The fact they can trigger antibodies on a stable portion of the virus is impressive. Near the end, it sounds like a multi pronged approach is needed to deal with variations. I’m not an immunologist, but it was pretty light. If they are in trials does that indicate they have a white paper?
- giantg2 2y ago"If they are in trials does that indicate they have a white paper?" I would think they'd have to in order to have the trial. It probably is not for public distribution though.
- heavyset_go 2y agoClinical trial data gets published online, might be able to find what you're looking for.